Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA as a multifunctional regulator in cancer multi-drug resistance
Jiaying He, Shaomi Zhu, Xin Liang, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 8, pp. 1-15
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou, Xiang Ao, Zhaojun Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79
lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways
Raed Obaid Saleh, Mushtak T.S. Al-Ouqaili, Eyhab Ali, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 16
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 14
Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
Ying Liu, Xiang Ao, Yu Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 65
LINC-PINT plays an anti-tumor role in nasopharyngeal carcinoma by binding to XRCC6 and affecting its function
Zhen Guo, KeYan Guan, Meihua Bao, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155460-155460
Closed Access | Times Cited: 12
LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a/RREB1 positive feedback loop and a ceRNA network
Qingzhuo Dong, Hui Qiu, Chiyuan Piao, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 18
Small Cell Lung Cancer—An Update on Chemotherapy Resistance
Ying Qian, Ruiyun Fan, Yili Shen, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1112-1123
Closed Access | Times Cited: 6
Circular RNAs as Key Regulators in Cancer Hallmarks: New Progress and Therapeutic Opportunities
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access
Long noncoding RNA MATN1-AS1 contributes to oxaliplatin resistance of gastric cancer cells through miR-518b/ZNF281 axis
Xuemei Qiu, Licheng Zhang, Fengying Guo, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
METTL3‐mediated m6A modification of lnc RNA RHPN1‐AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway
Shoubin Cui
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 12
Open Access | Times Cited: 20
METTL3-mediated m 6 A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis
Zhiyang Zhou, Yukun Cao, Yuan Yang, et al.
Epigenetics (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 11
LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells
Zhiwei Zhang, Yanli Yi, Zai Wang, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 6, pp. 1409-1423
Closed Access | Times Cited: 11
LncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis
Yufen Xu, Xiaoli Tan, Qi Yang, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 1-2, pp. 81-93
Closed Access | Times Cited: 3
Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications
Xiangyu Meng, Xiao Bai, Ang-Ting Ke, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 608-608
Open Access | Times Cited: 3
A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
Jingyi Wu, Jianzuo Yao, Shu Jia, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19352-e19352
Open Access | Times Cited: 9
Identification of associations between lncRNA and drug resistance based on deep learning and attention mechanism
Meihong Gao, Xuequn Shang
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters
Luděk Záveský, Eva Jandáková, Vít Weinberger, et al.
Cancer Biomarkers (2024) Vol. 40, Iss. 1, pp. 61-78
Open Access | Times Cited: 2
Evaluation of expression level of BANCR, MALAT1 and FER1L4 and their target genes in coumarin-treated AGS cell line
Shirin Shafaee Arani, Majid Nejati, Sepide Rastgoufar, et al.
Pathology - Research and Practice (2024) Vol. 257, pp. 155291-155291
Closed Access | Times Cited: 2
Deciphering the Role of Exosomal Non-Coding RNA (ncRNA) in Drug Resistance of Gastrointestinal Tumors; an Updated Review
Nafiseh Tashakori, Maryam Armanfar, A H Ziaee Mashhadi, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 609-621
Closed Access | Times Cited: 2
The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme
Liang Wang, Haiyan Cao, Ying Zhong, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 12
Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy
Jian-Lan Liu, Binlin Luo, Pengpeng Zhang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma
José A. Peña-Flores, Mercedes Bermúdez, Rosalío Ramos‐Payán, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Decoding the Oncogenic Signals from the Long Non-Coding RNAs
Revathy Nadhan, Danny N. Dhanasekaran
Onco (2021) Vol. 1, Iss. 2, pp. 176-206
Open Access | Times Cited: 14
Prognostic prediction of clear cell renal cell carcinoma based on lipid metabolism-related lncRNA risk coefficient model
Genyi Qu, Lu Liu, Lai Yi, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 5
The Functional Role of LncRNA UCA1 in Pancreatic Cancer: a mini-review
Cen-Cen Sun, Li Li, Zhichen Jiang, et al.
Journal of Cancer (2023) Vol. 14, Iss. 2, pp. 275-280
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top